IVERIC bio Initiating Second Pivotal Clinical Trial of Zimura® in GA with 1Q 2020 Targeted for First Patient Enrolled
NEW YORK--(BUSINESS WIRE)--IVERIC bio provided further clinical details and its development strategy for Zimura for the treatment of geographic atrophy secondary to dry AMD.